NYBC Ventures Launches $50M Fund to Accelerate Innovations in Blood and Cellular Therapies

NYBC Ventures announced the launch of its inaugural fund with a $50 million investment from New York Blood Center, Inc. (NYBC) to accelerate innovation in blood-related fields, and cellular therapies and enabling technologies.